Literature DB >> 26253829

Editorial comment on: Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.

Marcus Horstmann1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26253829     DOI： 10.1007/s11255-015-1075-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  2 in total

Review 1.  Peyronie's disease: review and recent advances.

Authors:  Joshua P Langston; Culley C Carson
Journal:  Maturitas       Date:  2014-06-06       Impact factor: 4.342

Review 2.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.

Authors:  Martin Gelbard; Irwin Goldstein; Wayne J G Hellstrom; Chris G McMahon; Ted Smith; James Tursi; Nigel Jones; Gregory J Kaufman; Culley C Carson
Journal:  J Urol       Date:  2013-01-31       Impact factor: 7.450
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.